“Ears of the Lynx” MRI Sign Is Associated with SPG11 and SPG15 Hereditary Spastic Paraplegia

References

1. 1.↵
   2. Chrestian N,
   3. Dupré N,
   4. Gan-Or Z, et al

   . Clinical and genetic study of hereditary spastic paraplegia in Canada. Neurol Genet 2017;3:e122 doi:10.1212/NXG.0000000000000122 pmid:27957547

   Abstract/FREE Full Text
2. 2.↵
   2. Goizet C,
   3. Boukhris A,
   4. Maltete D, et al

   . SPG15 is the second most common cause of hereditary spastic paraplegia with thin corpus callosum. Neurology 2009;73:1111–19 doi:10.1212/WNL.0b013e3181bacf59 pmid:19805727

   Abstract/FREE Full Text
3. 3.↵
   2. Hehr U,
   3. Bauer P,
   4. Winner B, et al

   . Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia. Ann Neurol 2007;62:656–65 doi:10.1002/ana.21310 pmid:18067136

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Kara E,
   3. Tucci A,
   4. Manzoni C, et al

   . Genetic and phenotypic characterization of complex hereditary spastic paraplegia. Brain 2016;139:1904–18 doi:10.1093/brain/aww111 pmid:27217339

   CrossRefPubMed
5. 5.↵
   2. Pensato V,
   3. Castellotti B,
   4. Gellera C, et al

   . Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. Brain 2014;137:1907–20 doi:10.1093/brain/awu121 pmid:24833714

   CrossRefPubMed
6. 6.↵
   2. Stevanin G,
   3. Azzedine H,
   4. Denora P, et al

   ; SPATAX consortium. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain 2008;131:772–84 doi:10.1093/brain/awm293 pmid:18079167

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Estrada-Cuzcano A,
   3. Martin S,
   4. Chamova T, et al

   . Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78). Brain 2017;140:287–305 doi:10.1093/brain/aww307 pmid:28137957

   CrossRefPubMed
8. 8.↵
   2. Eichler F,
   3. Ratai E,
   4. Carroll JJ, et al

   . Inherited or acquired metabolic disorders. Handb Clin Neurol 2016;135:603–36 doi:10.1016/B978-0-444-53485-9.00029- pmid:27432685

   CrossRefPubMed
9. 9.↵
   2. Abdel-Hamid MS,
   3. Issa MY,
   4. Otaify GA, et al

   . PGAP3-related hyperphosphatasia with mental retardation syndrome: report of 10 new patients and a homozygous founder mutation. Clin Genet 2018;93:84–91 doi:10.1111/cge.13033 pmid:28390064

   CrossRefPubMed
10. 10.↵
    2. Barmherzig R,
    3. Bullivant G,
    4. Cordeiro D, et al

    . A new patient with intermediate severe Salla disease with hypomyelination: a literature review for Salla disease. Pediatr Neurol 2017;74:87–91.e82 doi:10.1016/j.pediatrneurol.2017.05.022 pmid:28662915

    CrossRefPubMed
11. 11.↵
    2. Depienne C,
    3. Nava C,
    4. Keren B, et al

    . Genetic and phenotypic dissection of 1q43q44 microdeletion syndrome and neurodevelopmental phenotypes associated with mutations in ZBTB18 and HNRNPU. Hum Genet 2017;136:463–79 doi:10.1007/s00439-017-1772-0 pmid:28283832

    CrossRefPubMed
12. 12.↵
    2. Flex E,
    3. Niceta M,
    4. Cecchetti S, et al

    . Biallelic mutations in TBCD, encoding the tubulin folding cofactor D, perturb microtubule dynamics and cause early-onset encephalopathy. Am J Hum Genet 2016;99:962–73 doi:10.1016/j.ajhg.2016.08.003 pmid:27666370

    CrossRefPubMed
13. 13.↵
    2. Kurata H,
    3. Terashima H,
    4. Nakashima M, et al

    . Characterization of SPATA5-related encephalopathy in early childhood. Clin Genet 2016;90:437–44 doi:10.1111/cge.12813 pmid:27246907

    CrossRefPubMed
14. 14.↵
    2. Lamers IJC,
    3. Reijnders MR,
    4. Venselaar H, et al

    . Recurrent de novo mutations disturbing the GTP/GDP binding pocket of RAB11B cause intellectual disability and a distinctive brain phenotype. Am J Hum Genet 2017;101:824–32 doi:10.1016/j.ajhg.2017.09.015 pmid:29106825

    CrossRefPubMed
15. 15.↵
    2. Meng L,
    3. Donti T,
    4. Xia F, et al

    . Homozygous variants in pyrroline-5-carboxylate reductase 2 (PYCR2) in patients with progressive microcephaly and hypomyelinating leukodystrophy. Am J Med Genet A 2017;173:460–70 doi:10.1002/ajmg.a.38049 pmid:27860360

    CrossRefPubMed
16. 16.↵
    2. Rosti RO,
    3. Dikoglu E,
    4. Zaki MS, et al

    . Extending the mutation spectrum for Galloway-Mowat syndrome to include homozygous missense mutations in the WDR73 gene. Am J Med Genet A 2016;170A:992–98 doi:10.1002/ajmg.a.37533 pmid:27001912

    CrossRefPubMed
17. 17.↵
    2. Sidhu M,
    3. Brady L,
    4. Tarnopolsky M, et al

    . Clinical manifestations associated with the N-Terminal-Acetyltransferase NAA10 gene mutation in a girl: Ogden syndrome. Pediatr Neurol 2017;76:82–85 doi:10.1016/j.pediatrneurol.2017.07.010 pmid:28967461

    CrossRefPubMed
18. 18.↵
    2. Kraus MF,
    3. Susmaras T,
    4. Caughlin BP, et al

    . White matter integrity and cognition in chronic traumatic brain injury: a diffusion tensor imaging study. Brain 2007;130:2508–19 doi:10.1093/brain/awm216 pmid:17872928

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Mori S,
    3. Wakana S,
    4. van Zijl PC, et al

    . MRI Atlas of Human White Matter. Amsterdam: Elsevier; 2005, see: https://www.elsevier.com/books/mri-atlas-of-human-white-matter/mori/978-0-444-51741-8
20. 20.↵
    2. Riverol M,
    3. Samaranch L,
    4. Pascual B, et al

    . Forceps minor region signal abnormality “ears of the lynx”: an early MRI finding in spastic paraparesis with thin corpus callosum and mutations in the spatacsin gene (SPG11) on chromosome 15. J Neuroimaging 2009;19:52–60 doi:10.1111/j.1552-6569.2008.00327.x pmid:19040626

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Sze G,
    3. De Armond SJ,
    4. Brant-Zawadzki M, et al

    . Foci of MRI signal (pseudo lesions) anterior to the frontal horns: histologic correlations of a normal finding. AJR Am J Roentgenol 1986;147:331–37 doi:10.2214/ajr.147.2.331 pmid:3487952

    CrossRefPubMedWeb of Science
22. 22.↵
    2. de Bot ST,
    3. Burggraaff RC,
    4. Herkert JC, et al

    . Rapidly deteriorating course in Dutch hereditary spastic paraplegia type 11 patients. Eur J Hum Genet 2013;21:1312–15 doi:10.1038/ejhg.2013.27 pmid:23443022

    CrossRefPubMed
23. 23.↵
    2. França MC Jr.,
    3. D'Abreu A,
    4. Maurer-Morelli CV, et al

    . Prospective neuroimaging study in hereditary spastic paraplegia with thin corpus callosum. Mov Disord 2007;22:1556–62 doi:10.1002/mds.21480 pmid:17516453

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Hertzog MA

    . Considerations in determining sample size for pilot studies. Res Nurs Health 2008;31:180–91 doi:10.1002/nur.20247 pmid:18183564

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Landis JR,
    3. Koch GG

    . The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74 doi:10.2307/2529310 pmid:843571

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Stevanin G,
    3. Santorelli FM,
    4. Azzedine H, et al

    . Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet 2007;39:366–72 doi:10.1038/ng1980 pmid:17322883

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Faber I,
    3. Servelhere KR,
    4. Martinez ARM, et al

    . Clinical features and management of hereditary spastic paraplegia. Arq Neuropsiquiatr 2014;72:219–26 doi:10.1590/0004-282X20130248 pmid:24676440

    CrossRefPubMed
28. 28.↵
    2. Renvoisé B,
    3. Chang J,
    4. Singh R, et al

    . Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11. Ann Clin Transl Neurol 2014;1:379–89 doi:10.1002/acn3.64 pmid:24999486

    CrossRefPubMed
29. 29.↵
    2. Giannoccaro MP,
    3. Liguori R,
    4. Arnoldi A, et al

    . Atypical late-onset hereditary spastic paraplegia with thin corpus callosum due to novel compound heterozygous mutations in the SPG11 gene. J Neurol 2014;261:1825–27 doi:10.1007/s00415-014-7443-3 pmid:25059394

    CrossRefPubMed
30. 30.↵
    2. Fraidakis MJ,
    3. Brunetti M,
    4. Blackstone C, et al

    . Novel compound heterozygous spatacsin mutations in a Greek kindred with hereditary spastic paraplegia SPG11 and dementia. Neurodegener Dis 2016;16:373–81 doi:10.1159/000444715 pmid:27318863

    CrossRefPubMed
31. 31.↵
    2. Chakrabarty S,
    3. Vijayakumar N,
    4. Radhakrishnan K, et al

    . Spastizin mutation in hereditary spastic paraplegia with thin corpus callosum. J Neurol 2016;263:2130–32 doi:10.1007/s00415-016-8258-1 pmid:27544497

    CrossRefPubMed
32. 32.↵
    2. Pacheco FT,
    3. Rego MM,
    4. do Rego JI, et al

    . “Ears of the lynx” sign in a Marchiafava-Bignami patient: structural basis and fiber-tracking DTI contribution to the understanding of this imaging abnormality. J Neuroimaging 2014;24:205–07 doi:10.1111/j.1552-6569.2012.00714.x pmid:23216703

    CrossRefPubMed